Insider Selling: U.S. Physical Therapy, Inc. (USPH) Director Sells 2,000 Shares of Stock

U.S. Physical Therapy, Inc. (NYSE:USPH) Director Mark J. Brookner sold 2,000 shares of the stock in a transaction dated Monday, November 5th. The stock was sold at an average price of $113.75, for a total value of $227,500.00. The sale was disclosed in a document filed with the SEC, which is available at this link.

Mark J. Brookner also recently made the following trade(s):

  • On Friday, September 21st, Mark J. Brookner sold 2,500 shares of U.S. Physical Therapy stock. The stock was sold at an average price of $116.00, for a total value of $290,000.00.
  • On Friday, September 7th, Mark J. Brookner sold 625 shares of U.S. Physical Therapy stock. The stock was sold at an average price of $128.50, for a total value of $80,312.50.
  • On Thursday, August 23rd, Mark J. Brookner sold 4,375 shares of U.S. Physical Therapy stock. The stock was sold at an average price of $116.82, for a total value of $511,087.50.

Shares of USPH opened at $116.36 on Friday. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.93 and a quick ratio of 2.06. The stock has a market capitalization of $1.45 billion, a PE ratio of 55.94, a PEG ratio of 3.98 and a beta of 1.19. U.S. Physical Therapy, Inc. has a one year low of $66.65 and a one year high of $129.65.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Thursday, November 1st. The company reported $0.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.58 by $0.06. The business had revenue of $113.10 million during the quarter, compared to the consensus estimate of $112.79 million. U.S. Physical Therapy had a return on equity of 17.64% and a net margin of 5.58%. The company’s revenue for the quarter was up 9.8% compared to the same quarter last year. On average, sell-side analysts forecast that U.S. Physical Therapy, Inc. will post 2.56 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, December 7th. Shareholders of record on Friday, November 9th will be paid a dividend of $0.23 per share. The ex-dividend date is Thursday, November 8th. This represents a $0.92 dividend on an annualized basis and a yield of 0.79%. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 44.23%.

A number of analysts have weighed in on USPH shares. Jefferies Financial Group reiterated a “hold” rating and set a $105.00 price target on shares of U.S. Physical Therapy in a report on Friday, August 3rd. TheStreet downgraded U.S. Physical Therapy from a “b” rating to a “c+” rating in a research note on Friday, November 2nd. Cantor Fitzgerald raised their target price on U.S. Physical Therapy from $103.00 to $107.00 and gave the company a “neutral” rating in a research note on Friday, November 2nd. Zacks Investment Research upgraded U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $129.00 target price for the company in a research note on Tuesday, August 7th. Finally, Barrington Research restated a “hold” rating on shares of U.S. Physical Therapy in a research note on Friday, August 3rd. Four equities research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the stock. U.S. Physical Therapy presently has a consensus rating of “Buy” and a consensus price target of $113.67.

Hedge funds have recently added to or reduced their stakes in the business. Acadian Asset Management LLC acquired a new position in U.S. Physical Therapy during the 2nd quarter valued at about $106,000. Harvest Fund Management Co. Ltd acquired a new position in U.S. Physical Therapy during the 3rd quarter valued at about $190,000. Cambridge Investment Research Advisors Inc. acquired a new position in U.S. Physical Therapy during the 2nd quarter valued at about $219,000. Itau Unibanco Holding S.A. acquired a new position in U.S. Physical Therapy during the 2nd quarter valued at about $235,000. Finally, Sawtooth Solutions LLC acquired a new position in U.S. Physical Therapy during the 3rd quarter valued at about $291,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Insider Selling: U.S. Physical Therapy, Inc. (USPH) Director Sells 2,000 Shares of Stock” was published by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this news story can be accessed at https://sportsperspectives.com/2018/11/09/insider-selling-u-s-physical-therapy-inc-usph-director-sells-2000-shares-of-stock.html.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Read More: Should I follow buy, hold and sell recommendations?

Insider Buying and Selling by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply